• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 临床病程与血型:基于土耳其人群的研究。

COVID-19 clinical course and blood groups: Turkish population-based study.

机构信息

Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, Ankara, Turkey

Department of Strategy Development, Republic of Turkey, Ministry of Health, Ankara, Turkey

出版信息

Turk J Med Sci. 2021 Aug 30;51(4):1659-1664. doi: 10.3906/sag-2101-321.

DOI:10.3906/sag-2101-321
PMID:33957720
Abstract

BACKGROUND/AIM: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin- converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 was inhibited by anti-A antibodies. The aim of the study was to investigate the relationship between blood groups and the course of COVID-19 in Turkey.

MATERIALS AND METHODS

Laboratory confirmed COVID-19 patients aged 18 and over (n = 39.850) were randomized in age and sex- matched groups according to blood groups.

RESULTS

Advanced age, male sex and blood group A were found to be related with increased rate of intensive care unit (ICU) admission (OR = 1.089, 95% CI: 1.085–1.093 for age; OR = 1.963, 95% CI: 1.737–2.218 for male sex; OR = 1.216, 95% CI: 1.023–1.446 for blood group A). When blood group O individuals were compared to non-O individuals, no significant difference was observed regarding the rate of hospital and ICU admission, mechanical ventilation (MV) support, length of hospital and ICU stay, and case fatality rate (CFR). The CFR in patients with blood group A, B, O, and AB were 2.6%, 2.2%, 3.1%, and 2.3%, respectively. There were no significant differences between Rh-negative and positive patients regarding the rate of hospital and ICU admission (p = 0.280 and p = 0.741, respectively), also the rate of MV support and CFR was similar (p = 0.933 and p = 0.417).

CONCLUSION

Our study revealed that ABO and Rh blood groups do not have any impact on the rate of hospital admission, hospital and ICU stay, MV support, and CFR.

摘要

背景/目的:SARS-CoV-2 通过病毒表面的 S 糖蛋白与宿主细胞中的血管紧张素转换酶 2(ACE-2)结合进入细胞,SARS-CoV 的 S 蛋白与 ACE-2 的结合也被抗-A 抗体所抑制。本研究旨在探讨土耳其人群中血型与 COVID-19 病程之间的关系。

材料和方法

根据血型将年龄和性别匹配的实验室确诊 COVID-19 患者(n = 39.850)随机分为年龄和性别匹配的组。

结果

研究发现,高龄、男性和血型 A 与 ICU 入住率升高相关(OR = 1.089,95%CI:1.085-1.093 年龄;OR = 1.963,95%CI:1.737-2.218 男性;OR = 1.216,95%CI:1.023-1.446 血型 A)。与非 O 血型个体相比,O 血型个体的住院和 ICU 入住率、机械通气(MV)支持、住院和 ICU 停留时间以及病死率(CFR)无显著差异。A、B、O 和 AB 血型患者的 CFR 分别为 2.6%、2.2%、3.1%和 2.3%。Rh 阴性和阳性患者的住院和 ICU 入住率无显著差异(p = 0.280 和 p = 0.741),MV 支持率和 CFR 也相似(p = 0.933 和 p = 0.417)。

结论

本研究表明,ABO 和 Rh 血型对住院率、住院和 ICU 停留时间、MV 支持率和 CFR 无影响。

相似文献

1
COVID-19 clinical course and blood groups: Turkish population-based study.COVID-19 临床病程与血型:基于土耳其人群的研究。
Turk J Med Sci. 2021 Aug 30;51(4):1659-1664. doi: 10.3906/sag-2101-321.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.接受酪氨酸激酶抑制剂治疗的慢性髓性白血病患者的COVID-19结局
J Oncol Pharm Pract. 2020 Oct;26(7):1676-1682. doi: 10.1177/1078155220953198. Epub 2020 Aug 27.
4
Characteristics and Outcomes Based on Perceived Illness Severity in SARS-CoV-2.基于新型冠状病毒肺炎(SARS-CoV-2)感知疾病严重程度的特征和结局
South Med J. 2020 Dec;113(12):618-622. doi: 10.14423/SMJ.0000000000001182.
5
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
6
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).土耳其 2 型糖尿病患者 COVID-19 的临床特征和结局:一项全国性研究(TurCoviDia)。
J Diabetes. 2021 Jul;13(7):585-595. doi: 10.1111/1753-0407.13171. Epub 2021 Mar 24.
7
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.在纽约一家医院中对 4404 人进行的 COVID-19 调查队列研究,以及 ICU 护理和通气的预测因素。
Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11.
8
The outcome of COVID-19 in patients with hematological malignancy.COVID-19 患者的血液恶性肿瘤结局。
J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.
9
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.瑞士全国移植等待名单上的 SARS-CoV-2/COVID-19 患者。
Swiss Med Wkly. 2020 Dec 31;150:w20451. doi: 10.4414/smw.2020.20451. eCollection 2020 Dec 14.
10
Demographic characteristics, acute care resource use and mortality by age and sex in patients with COVID-19 in Ontario, Canada: a descriptive analysis.加拿大安大略省 COVID-19 患者的年龄和性别与人口统计学特征、急性护理资源使用和死亡率:描述性分析。
CMAJ Open. 2021 Mar 22;9(1):E271-E279. doi: 10.9778/cmajo.20200323. Print 2021 Jan-Mar.

引用本文的文献

1
Association Between Rhesus and ABO Blood Group Types and Their Impact on Clinical Outcomes in Critically Ill Patients with COVID-19: A Multi-Center Investigation.恒河猴血型和ABO血型与新型冠状病毒肺炎重症患者临床结局的关联:一项多中心调查
Infect Drug Resist. 2024 Jul 19;17:3161-3171. doi: 10.2147/IDR.S447010. eCollection 2024.
2
The Relationship of ABO and Rh Blood Group Types With Severe COVID-19 Disease Mortality in ICU Patients: Insights From a Single-Center Experience in Southern Saudi Arabia.ABO和Rh血型与ICU患者中重症COVID-19疾病死亡率的关系:来自沙特阿拉伯南部单中心经验的见解
Cureus. 2023 Dec 22;15(12):e50935. doi: 10.7759/cureus.50935. eCollection 2023 Dec.
3
Sex and ABO Blood Differences in SARS-CoV-2 Infection Susceptibility.
新型冠状病毒2型感染易感性中的性别和ABO血型差异
Glob Med Genet. 2023 Jan 30;10(1):22-26. doi: 10.1055/s-0043-1761202. eCollection 2023 Jan.
4
Effects of ABO blood groups and RH-factor on COVID-19 transmission, course and outcome: A review.ABO血型和Rh因子对新型冠状病毒肺炎传播、病程及预后的影响:一项综述
Front Med (Lausanne). 2023 Jan 12;9:1045060. doi: 10.3389/fmed.2022.1045060. eCollection 2022.
5
Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort.A型血是土耳其队列中 COVID-19 感染和住院的风险因素。
Transfus Clin Biol. 2023 Feb;30(1):116-122. doi: 10.1016/j.tracli.2022.10.003. Epub 2022 Oct 13.
6
Predictors of COVID-19 severity and hospitalization: A survey-based study from Jordan.新冠病毒疾病严重程度及住院治疗的预测因素:一项来自约旦的基于调查的研究。
Inform Med Unlocked. 2022;31:100994. doi: 10.1016/j.imu.2022.100994. Epub 2022 Jun 14.
7
ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study.ABO 血型与 COVID-19 患者并发症发生率的关系:一项基于人群的前瞻性队列研究。
Int J Environ Res Public Health. 2021 Sep 24;18(19):10039. doi: 10.3390/ijerph181910039.
8
Association between blood groups and COVID-19 outcome in Iranian patients.伊朗患者血型与新冠病毒病结局之间的关联
Future Virol. 2021 Aug. doi: 10.2217/fvl-2021-0090. Epub 2021 Sep 22.